ArticleJCO oncology practice2025
Incomplete Toxicity Reporting and Use of Toxicity-Minimizing Language in Phase III Oncology Trials.
Avital M Miller et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it